Yifei Feng

Publication Activity (10 Years)

Years Active: 2022-2022
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Long Non Coding Rna

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Tuo Wang, Chi Jin, Peng Yang, Zhihao Chen, Jiangzhou Ji, Qingyang Sun, Sheng Yang, Yifei Feng, Junwei Tang, Yueming Sun
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene 42 (9) (2022)
Tuo Wang, Chi Jin, Peng Yang, Zhihao Chen, Jiangzhou Ji, Qingyang Sun, Sheng Yang, Yifei Feng, Junwei Tang, Yueming Sun
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene (2022)
Tuo Wang, Chi Jin, Peng Yang, Zhihao Chen, Jiangzhou Ji, Qingyang Sun, Sheng Yang, Yifei Feng, Junwei Tang, Yueming Sun
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene 42 (9) (2022)
Tuo Wang, Chi Jin, Peng Yang, Zhihao Chen, Jiangzhou Ji, Qingyang Sun, Sheng Yang, Yifei Feng, Junwei Tang, Yueming Sun
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene 42 (9) (2022)
Tuo Wang, Chi Jin, Peng Yang, Zhihao Chen, Jiangzhou Ji, Qingyang Sun, Sheng Yang, Yifei Feng, Junwei Tang, Yueming Sun
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene 42 (9) (2022)
Tuo Wang, Chi Jin, Peng Yang, Zhihao Chen, Jiangzhou Ji, Qingyang Sun, Sheng Yang, Yifei Feng, Junwei Tang, Yueming Sun
UBE2J1 inhibits colorectal cancer progression by promoting ubiquitination and degradation of RPS3. Oncogene 42 (9) (2022)